SOADOR
EBS icon

State of Alaska Department of Revenue’s Emergent Biosolutions EBS Stock Holding History

State of Alaska Department of Revenue’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29,542
Closed -$217K – 1616
2023
Q2 		$217K Sell
29,542
-862
-3% -$7.99K ﹤0.01% 1590
2023
Q1 		$314K Sell
30,404
-513
-2% -$6.2K ﹤0.01% 1531
2022
Q4 		$365K Buy
30,917
+193
+0.6% +$2.99K ﹤0.01% 1481
2022
Q3 		$644K Sell
30,724
-3,101
-9% -$86.3K 0.01% 1169
2022
Q2 		$1.05M Buy
33,825
+430
+1% +$14.7K 0.01% 934
2022
Q1 		$1.37M Sell
33,395
-510
-2% -$22.5K 0.01% 828
2021
Q4 		$1.47M Buy
33,905
+26,367
+350% +$1.19M 0.01% 864
2021
Q3 		$377K Buy
7,538
+506
+7% +$30.6K ﹤0.01% 1543
2021
Q2 		$442K Sell
7,032
-65
-0.9% -$4.18K ﹤0.01% 1488
2021
Q1 		$659K Sell
7,097
-223
-3% -$22.8K 0.01% 1283
2020
Q4 		$655K Sell
7,320
-339
-4% -$31.1K 0.01% 1207
2020
Q3 		$791K Sell
7,659
-34,378
-82% -$3.71M 0.01% 1003
2020
Q2 		$3.32M Buy
42,037
+1,330
+3% +$99.1K 0.04% 449
2020
Q1 		$2.35M Buy
40,707
+7,570
+23% +$436K 0.04% 458
2019
Q4 		$1.79M Sell
33,137
-560
-2% -$30.4K 0.02% 621
2019
Q3 		$1.76M Buy
33,697
+18,299
+119% +$853K 0.02% 589
2019
Q2 		$743K Buy
15,398
+209
+1% +$10K 0.01% 881
2019
Q1 		$767K Buy
15,189
+200
+1% +$11.8K 0.01% 843
2018
Q4 		$888K Buy
14,989
+737
+5% +$47.5K 0.02% 693
2018
Q3 		$938K Buy
14,252
+2,681
+23% +$156K 0.02% 756
2018
Q2 		$584K Buy
11,571
+250
+2% +$13K 0.01% 975
2018
Q1 		$596K Buy
11,321
+4,340
+62% +$216K 0.01% 856
2017
Q4 		$324K Buy
6,981
+70
+1% +$2.95K 0.01% 998
2017
Q3 		$279K Buy
6,911
+40
+0.6% +$1.45K 0.01% 882
2017
Q2 		$232K Buy
6,871
+3,051
+80% +$94.2K 0.02% 795
2017
Q1 		$110K Buy
3,820
+100
+3% +$3.04K 0.01% 906
2016
Q4 		$122K Buy
+3,720
New +$112K 0.01% 587

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Alaska Department of Revenue's EBS Position: Q3 2023 in Review

State of Alaska Department of Revenue sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 29,542 shares — an estimated $217K sold.

State of Alaska Department of Revenue first reported a position in EBS in Q4 2016 and held it in 27 quarters. The position peaked at $3.32M in Q2 2020. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • State of Alaska Department of Revenue reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 29,542 Emergent Biosolutions shares in Q3 2023, an estimated $217K.
  • State of Alaska Department of Revenue first reported a position in Emergent Biosolutions in Q4 2016 and held it in 27 quarters.
  • State of Alaska Department of Revenue's Emergent Biosolutions position peaked at $3.32M in Q2 2020.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2023, filed 16 Oct 2023.